Open menu
Paytm Money logo
search-placeholder
search
Mutual Fund Details
search-placeholder
search
Tata Mutual Fund

Tata India Pharma & HealthCare Fund Direct - Growth

NAV
returns change indicator
14.1378
as on 14 Aug 2020, 10:55 PM
0.0999(0.71%)
Last Change
loaderloader

Schemes Managed By

Start SIP in this Mutual Fund

Min SIP Amount
500
Suggested Date
17th of Every Month

Investment Performance

would have given a return of
110,871
star
121,647
star
161,138
star
169,429
star
Bank Account
Fixed Deposit
Regular Mutual Fund
This Fund on Paytm Money
This Mutual Fund
69,429
Profit (absolute return)
69.43%
in the last
1m
3m
1y
3y
max
+1% Higher Returns
With Direct Plans on Paytm Money

Investment Returns

In the last 3 months
21.86%
In the last 6 months
30.88%
In the last 1 year
52.62%
In the last 3 years
69.43%
In the last 5 years
NA
In the last 10 years
NA
Absolute Returns
CAGR

Scheme Riskometer

low
low
moderately low
moderately low
moderate
moderate
moderately high
moderately high
high
high
indicator
Investors understand that their principal will be at high risk

Scheme Information

Tata India Pharma & HealthCare Fund Direct - Growth
Tata India Pharma & HealthCare Fund Direct - Growth
as of 31 Jul 2020, 05:30 AM
272.79 Cr
Scheme Asset Size
Fund Type
Open-End
Exit Load
For units in excess of 12% of the investment,1% will be charged for redemption within 365 Days.
1.20%
Expense Ratio
Plan
Growth
2.20%
Cash Holding
Benchmark
NIFTY Pharma Total Return Index
Scheme Document
Benchmark
NIFTY Pharma Total Return Index
Exit Load
For units in excess of 12% of the investment,1% will be charged for redemption within 365 Days.
Scheme Document

Sectors Holding in this Mutual Fund

as on 31 Jul 2020
Sort By
Healthcare
97.80%
266.78 Cr
Cash Holding
2.20%
6.00 Cr

Companies Holding in this Mutual Fund

as on 31 Jul 2020
Sort By
Dr. Reddy's Laboratories Ltd.
17.29%
47.16 Cr
Sun Pharmaceutical Inds. Ltd.
16.96%
46.26 Cr
Divi's Laboratories Ltd.
9.83%
26.81 Cr
Lupin Ltd.
7.57%
20.65 Cr
Ipca Laboratories Ltd.
6.53%
17.81 Cr
Cipla Ltd.
6.07%
16.56 Cr
Aurobindo Pharma Ltd.
5.61%
15.30 Cr
Narayana Hrudayalaya Ltd.
4.07%
11.10 Cr
Procter & Gamble Health Ltd.
3.96%
10.80 Cr
Natco Pharma Ltd.
3.59%
9.79 Cr
View All
View All

About Tata India Pharma & HealthCare Fund Direct - Growth

Tata India Pharma & HealthCare Fund Direct - Growth is a Equity mutual fund scheme from Tata Mutual Fund. This scheme was launched on 28 Dec 2015 and is currently managed by its fund manager Sailesh Jain. It has an AUM of ₹272.79 Crores and the latest NAV decalared is ₹14.138 as on 15 Aug 2020 at 1:06 am.
Tata India Pharma & HealthCare Fund Direct - Growth scheme return performance in last 1 year is 52.62%, in last 3 years is 69.43% and 39.89% since scheme launch. The min. SIP amount to invest in this scheme is ₹500.

Scheme Details

AUM:272.79 Cr
Category:Equity: Sectoral-Pharma
Launch Date:28 Dec 2015
Fund Type:Open-End

Scheme Objective

The scheme seeks long term capital appreciation by investing atleast 80% of it's net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India.

AMC Information

Tata Mutual Fund
Tata Mutual Fund
View AMC Details
56,694.28 Cr
AUM
96
Schemes
Address
Address
9th Floor, Mafatlal Centre,Nariman Point,400021
Phone Number
Phone Number
Phone : 1800-209-0101